Showing results 1 to 2 of 2
| Issue Date | Title | Journal Title |
|---|---|---|
| 2025 | Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial | NATURE MEDICINE |
| 2025 | Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer | NEW ENGLAND JOURNAL OF MEDICINE |